Glass of Red Wine Protects Against Prostate Cancer: Study

Glass of Red Wine Protects Against Prostate Cancer: Study


Moderate red wine consumption does not significantly increase the risk of prostate cancer according to new research, and in fact could have a slight protective effect.

Carried out by an international research team led by Shahrokh Shariat at the Medical University of Vienna in Austria, the new meta-analysis looked at whether moderate wine consumption had an effect on the risk of developing prostate cancer, the most common form of cancer in the Western world. 

Fifteen to 20 percent of men are affected by prostate cancer at some time in their lives and 2.6 percent die from the disease.  > >> read more ...

Panel Leaves Prostate Screening up to Men and Their Doctors

Panel Leaves Prostate Screening up to Men and Their Doctors


Whether to get screened for prostate cancer is a question that men aged 55 to 69 should decide themselves in consultation with their doctors, according to finalized guidance issued Tuesday by an influential panel of health care experts.

New evidence suggests that PSA blood tests can slightly reduce the chances of dying from the disease for some men, so those decisions may be a little easier. Though screening can sometimes lead to drastic, needless treatment, the panel says that can sometimes be avoided with close monitoring when cancer is detected. > >> read more ...

Gene Can Turn Off Fat That Causes Prostate Cancer: Report

Gene Can Turn Off Fat That Causes Prostate Cancer: Report

A diet high in fat — such as that typically found in the United States — has long been suspected of fueling prostate cancer growth, and researchers think they have found a way to shut down the destructive mechanism of that fat, a report in Science Daily shows.

Researchers at the Cancer Center at Beth Israel Deaconess Medical Center (BIDMC) set out to determine the genetic mechanisms that promote metastasis — accelerated growth — in prostate cancer. Prostate tumors tend to be slow growing; so slow, men with prostate cancer tend to die with it, not from it. It’s only when prostate tumors metastasize that the disease is fatal.  > >> read more ...

Light Breakfast Boosts Prostate Cancer Drug’s Power

Light Breakfast Boosts Prostate Cancer Drug’s Power


Here’s one way to cut the cost of a $10,000-a-month prostate cancer drug: Take it with food, some researchers suggest.

Investigators said they found that taking Zytiga (abiraterone acetate) with a low-fat breakfast boosts its efficiency. That could make it more convenient and significantly cheaper, the new study suggested.

Zytiga is the standard medicine for prostate cancer that has spread and has progressed despite hormonal therapy. Patients are told to take four 250-milligram pills first thing in the morning, then wait an hour before eating breakfast. > >> read more ...

Actor Stephen Fry Fighting Prostate Cancer

Actor Stephen Fry Fighting Prostate Cancer


British actor and comedian Stephen Fry revealed on Friday he has been battling prostate cancer, adding that he was currently “fit and well”.

The 60-year-old wrote on Twitter that over the last two months he had “been in the throes of a rather unwelcome and unexpected adventure”.

“I’m sorry I haven’t felt able to talk about it (until) now, but here I am explaining what has been going on,” he said, posting a link to a video message on his personal website. > >> read more ...

New Therapy Targets Hard-to-Treat Prostate Cancer

New Therapy Targets Hard-to-Treat Prostate Cancer


The U.S. Food and Drug Administration on Wednesday approved Johnson & Johnson’s Erleada treatment for use in prostate cancer patients whose cancer has not spread but continues to grow despite hormone therapy.

The drug is the first FDA-approved treatment for non-metastatic, castration-resistant prostate cancer, the regulator said. 

The approval was based on a trial goal that measured the length of time tumors did not spread to other parts of the body, or death occurred after starting the treatment, the FDA said. > >> read more ...

error: Content is protected !!